Search This Blog

Friday, September 15, 2023

Iovance: FDA Updates PDUFA Date for Lifileucel for Melanoma

Priority Review Continues with Successful Facility Inspections Completed,
no Major Review Issues

FDA Extends PDUFA Date to February 24, 2024 on Resource Constraints and Agrees to Work with Iovance to Expedite Remaining Review

https://finance.yahoo.com/news/u-food-drug-administration-updates-221000095.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.